The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2023Evaluation of a Digital Therapeutics (DTx) Mobile App and Algorithm for Personalized Medication and Treatment Plan Optimization for People with Parkinson’s Disease
Study Rationale: People with Parkinson’s disease (PD) have few options for keeping their symptoms under control. An app that could automatically monitor PD symptoms, like tremors, could allow users to...
-
Translational Pipeline Program, 2022Prevention of Dementia in GBA-associated Parkinson’s Disease
Study Rationale: Whereas motor symptoms can be well controlled by dopamine-enhancing drugs and deep brain stimulation, dementia represents a key milestone in the course of Parkinson’s disease (PD)...
-
Research Grant, 2023Ensuring Diversity and Equity in Parkinson’s Disease Research and Care
Study Rationale: Parkinson’s disease (PD) is one of the most common neurodegenerative disorders across the world. PD has a negative impact on a person’s mobility and their ability to carry out...
-
Biomarkers to Support Therapeutic Trials Program, 2023Analyzing the Aggregation Properties of Alpha-synuclein in Different Genetic Subtypes of Parkinson’s Disease
Study Rationale: Abnormal clumping of alpha-synuclein appears to be an important cause for the death of dopamine cells in Parkinson disease (PD). Recent studies discovered that small amounts of tiny...
-
Research Grant, 2023Evaluating a Gene Therapy that Restores Mitochondrial Function as a Treatment for Parkinson’s Disease
Study Rationale: Currently, all treatments for Parkinson’s disease (PD) aim to improve symptoms by restoring or maintaining the levels of dopamine in the brain. No treatment on the market slows or...
-
Research Grant, 2022Evaluation of Assessments Made by Digital Health Technology
Study Rationale: The development of drugs that can slow or halt the progression of Parkinson’s disease (PD) can be expensive and take a long time. Although there are many promising new therapeutics in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.